Southern States Slowly Embracing Harm Reduction to Curb Opioid Epidemic

Two University of Miami medical students examine the track marks of a patient at the IDEA Exchange, which offers free wound care and HIV screenings. Southern states are beginning to embrace harm reduction techniques, including needle exchanges.

Two University of Miami medical students examine the track marks of a patient at the IDEA Exchange, which offers free wound care and HIV screenings. Southern states are beginning to embrace harm reduction techniques, including needle exchanges. The Pew Charitable Trusts

 

Connecting state and local government leaders

Activists are convincing conservative Southerners to buy in to needle exchanges.

This story was originally published by Stateline, an initiative of The Pew Charitable Trusts.

As a top agent with North Carolina’s Bureau of Investigation, Donnie Varnell had tried everything to stop people from fatally overdosing on opioids, from arresting more low-level drug users to talking with doctors. Nothing worked.

In 2014, he heard a former SWAT commander speak to law enforcement officers about carrying the opioid antidote naloxone.

“I’ve arrested more people than you can put on a cruise ship,” Varnell said, recalling the speech. “But the message—and the messenger—resonated with me. He spoke cop. But he also had ideas, programs and studies. I could see naloxone wasn’t dangerous.”

Soon Varnell was traveling the state, working with drug policy activists to convince other officers to carry the overdose-reversal drug. He also embraced syringe exchanges, using data — nearly 1 in 3 officers get stuck with a syringe during the course of their career — to persuade fellow officers to support exchanges.

And he even educated police chiefs concerned about the costs and liability of naloxone and needles.

Since the 1990s, activists in cities such as Chicago, San Francisco and New York have led the nation in practicing harm reduction, a set of tools such as needle exchanges and naloxone distribution designed to help people addicted to drugs make incremental improvements to their health.

But in the Bible Belt, many Southerners who held conservative views often criticized harm reduction as something that encouraged—not ended—the use of drugs. Those practices, in many states, were banned outright.

But attitudes have shifted, given the sheer scale of the epidemic, proof that some harm reduction efforts save lives as well as taxpayer dollars, and the changing cultural view of drug users.

“Over time, harm reduction became seen as something that’s common sense,” said Michael-Devereux Louis Bertin, executive director of the South Carolina Harm Reduction Coalition. “There’s a whole new wave of support for harm reduction in the South.”

This shift comes at a time when Southern states, like the rest of the nation, are searching for ways to reverse the trend of rising opioid deaths. In 2014, when nearly 29,000 Americans died from opioids, no Southern state had allowed for both needle exchanges and naloxone.

With the national death toll of opioid-involved drug overdoses exceeding 47,000 in 2017, every Southern state has approved giving drug users access to the antidote without a prescription, according to CVS Health.

And following the lead of Kentucky and North Carolina, Georgia this month enacted a law and Florida is close to approving its own to expand the distribution of sterile syringes to help drug users avoid spreading HIV, hepatitis C and other infectious diseases.

“This type of legislation hasn’t always been popular with our majority party,” said Georgia Republican state Sen. Kay Kirkpatrick, a surgeon and one of the sponsors of a needle exchange bill that recently passed.

“But our opioid problem has gotten more attention,” she said. “And when President Trump made getting rid of HIV a priority, blessing what hadn’t been popular before, it opened the way for harm reduction.”

The Trump administration has increasingly embraced the use of some harm reduction techniques. Last spring U.S. Surgeon General Jerome Adams issued a rare public health advisory that urged people at risk of opioid overdose—as well as their loved ones—to carry naloxone.

More recently, U.S. Health Secretary Alex Azar publicly supported syringe exchanges. However, the Department of Justice has filed a lawsuit in an effort to block a plan for a supervised consumption site in Philadelphia, which was set to be the first of its kind.

Despite the progress, activists say hurdles remain throughout the region. Many Georgia school leaders have yet to stock nurses’ offices with naloxone. Lawmakers in Alabama and Louisiana, meanwhile, have effectively blocked recent bills to fully legalize syringe exchanges.

Many states, following the Trump administration’s lead, have bristled at newer tools such as safe-consumption sites that are now being considered in some American cities.

“Change is complicated,” said Louise Vincent, executive director of the North Carolina chapter of the Urban Survivors Union, a grassroots advocacy group comprised of current and former drug users. “We’ve tried to scare and jail people. We’ve spent trillions. It wasn’t working.

“The evidence is clear for harm reduction,” Vincent said. “If we can move away from fear toward compassion, it’s totally possible to get people on board.”

Before 2013, Tanya Smith never imagined she’d carry naloxone. But the Holly Springs, Georgia, police officer got the call every parent fears: Her 20-year-old daughter, Taylor, had been found on the side of the road after a heroin overdose.

Months after Taylor’s death, a college student asked if Smith would help lobby for medical amnesty legislation to provide immunity to Georgia drug users who call 911 to report a drug overdose, as well as allow officers to carry naloxone.

Smith liked the bill but doubted it would pass. The main hurdle: Members of her profession.

“I thought, ‘We’re in the South,’” Smith said, referring to the long-held religious and cultural beliefs that promote helping people only when they’re drug-free. “As police officers, we’re trained that it’s a crime to possess drugs. I knew it would take a lot to shift their thinking.”

But as more officers responded to overdose calls and saw the need for naloxone firsthand, Smith started lobbying. Within a year of Taylor’s overdose, Smith helped secure the bill’s passage. The Holly Springs Police Department became the first in the state to carry naloxone.

In 2015, when the Kentucky legislature was considering allowing naloxone access without a prescription, Republican state Sen. Whitney Westerfield recalls, his colleagues feared the antidote would encourage people to keep using drugs.

But fellow officials have come around, in part because they’ve seen the drug’s lifesaving potential, he said. Since 2015, when Kentucky began allowing pharmacies to sell naloxone without a prescription, drug users have been able to inject friends who have overdosed.

In a 2018 NPR national poll, more than half of respondents said they were aware of naloxone and would administer it. (The poll did not track for political affiliation.)

Recently, activists across the South have handed out free naloxone everywhere from the back of a Mississippi bike shop to a North Carolina church. And a growing number of health departments in Kentucky, Alabama and Louisiana have distributed the antidote for free.

Tanya Smith, for her part, has spent much of the past five years convincing other police officers to carry the drug. Thanks to her advocacy, new recruits learn about naloxone during their time in the police academy.

“Naloxone is giving them [drug users] a second chance,” Smith said.

Needle Exchanges

Since World AIDS Day 2016, Florida drug users have gathered in a parking lot near Miami’s Overtown neighborhood. Inside three drab tan trailers, University of Miami-affiliated doctors and medical students distribute sterile syringes six days a week while also providing HIV and hepatitis C testing, wound care and naloxone.

They hope to build a bond with patients in hopes of someday referring them to addiction treatment once they’re ready to quit using.

“The methods of harm reduction are reducing recidivism in the emergency department,” said Eddy Suarez Jr., the community engagement supervisor with the Miami program, known as the IDEA Exchange. “They’re getting help. Then they’re getting into treatment and recovery.”

The road to distributing syringes, however, hasn’t been easy in Florida. State lawmakers had banned needle exchanges until three years ago, when they allowed Miami-Dade County to be a state pilot, so long as it didn’t use taxpayer dollars.

A drug user drops a series of used syringes into a wastebasket. Florida state law limits Miami's IDEA exchange from distributing only one sterile syringe for every discarded one it collects. (The Pew Charitable Trusts)

With the help of private donors, a team led by Dr. Hansel Tookes has since collected more than a quarter-million used syringes, reducing the number of syringes on the street by roughly half since 2009.

While parts of Florida have seen opioid deaths rise, Miami-Dade’s fatal overdoses are falling, according to figures reported to the Florida Department of Health.

Tookes has sent a small army of medical students to the statehouse to convince lawmakers to support a bill to allow counties to decide whether to let exchanges open. As of last week, Florida lawmakers needed just a full House vote to pass the bill. But government funding likely will be restricted.

Florida’s conservative lawmakers, many of whom had once been skeptics of syringe distribution, have become supporters after seeing the IDEA Exchange curb the local epidemic on a shoestring budget. Republican House Speaker Jose Oliva has praised the program for being “cost-effective” and “solution-centric.”

In recent months, the Trump administration’s public backing of syringe exchanges has given conservative lawmakers one more reason to support such efforts.

During a recent speech at the National HIV Prevention Conference in Washington, D.C., U.S. Health Secretary Alex Azar said syringe exchanges “aren’t necessarily the first thing that comes to mind when you think about a Republican health secretary.” However, he noted, “the public health evidence … is strong.”

Needle exchanges can both reduce the spread of transmittable disease and save government agencies more than $7 for every dollar spent, according to the Centers for Disease Control and Prevention.

Opposition

Despite the federal government’s backing, a 2018 national survey conducted by Johns Hopkins researchers found that only 39% of respondents supported needle exchanges. For signs of that opposition, look no further than Alabama and Louisiana.

During a debate last year that stalled a syringe exchange bill, Republican state Sen. Larry Stutts argued that providing syringes wouldn’t make drug use safer.

“There are some things you cannot make safe,” Stutts said, “and IV drug use is on that list.” 

Louisiana Democratic state Rep. Ted James said a similar bill stalled there last year because of his colleagues’ tendency to “legislate from a position of fear.” He wants to try again next year, emphasizing the fiscal benefits of syringe exchange.

Still, he’s preparing for lawmakers to repeat their concerns that syringe distribution would “give drug dealers a free pass.”

Kentucky’s Westerfield, for his part, still thinks some of his colleagues are uneasy about the existence of more than 50 syringe exchanges in the state. But he’s still hopeful that the results will mirror that of the CDC’s research, which shows that injection drug users who have access to syringe exchanges are five times more likely to get treatment than those who don’t.

“There’s not universal support, but we’ve moved in that direction,” Westerfield said. “I don’t see the people who hated [needle exchange] filing bills to reverse it. With harm reduction, there’s more general acceptance of it.”

Georgia Republican state Rep. Houston Gaines thinks naloxone and needle distribution will help curb the opioid epidemic in his state. But there are limits to his harm reduction advocacy. Case in point: Safe injection sites.

“Georgia isn’t trying to be California,” Gaines said. “I’m not in favor of them. I’ve not seen enough research that it’s making an impact, and the trade-off is increased crime rates.”

In cities like San Francisco, many lawmakers say that such facilities would let drug users inject drugs under the supervision of medical staff, which would reduce fatal overdoses. However, Southern harm reduction activists are divided.

Bertin fears the image of a building full of drug users injecting heroin might scare conservative lawmakers from supporting any kind of harm reduction tactic. Varnell, for his part, sees it as a “non-starter” with law enforcement in North Carolina.

But the perception there, too, could change. The officer Varnell had seen on that harm reduction panel, Fayette Police Department Capt. Lars Paul, said he’d support safe consumption sites “if it’s proven by science and studies, and politicians and the public approved.”

“My personal opinion?” Paul asked. “This problem is so bad that we need to consider trying anything new.”

Editor's note: An earlier version of this story misstated the number of syringe exchanges in Kentucky.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.